Guanylate cyclase-C agonists

FL 145 Pill - white capsule-shape

Generic Name: linaclotide

Pill with imprint FL 145 is White, Capsule-shape and has been identified as Linzess 145 mcg. It is supplied by Allergan, Inc.

Linzess is used in the treatment of Chronic Idiopathic Constipation; Irritable Bowel Syndrome with Constipation; Functional Constipation and belongs to the drug class guanylate cyclase-C agonists. Risk cannot be ruled out during pregnancy. Linzess 145 mcg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Linzess (Linaclotide [ lin-a-kloe-tide ])-FL 145-145 mcg-White-Capsule-shape
Linzess (Linaclotide [ lin-a-kloe-tide ])-FL 145-145 mcg-White-Capsule-shape
Linzess (Linaclotide [ lin-a-kloe-tide ])-FL 145-145 mcg-White-Capsule-shape
Linzess (Linaclotide [ lin-a-kloe-tide ])-FL 145-145 mcg-White-Capsule-shape

Linzess
Generic Name: linaclotide [ lin-a-kloe-tide ]
Imprint: FL 145
Strength: 145 mcg
Color: White
Size: N/A
Shape: Capsule-shape
Availability: Prescription only
Drug Class: Guanylate cyclase-C agonists
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 00456-1201
Inactive Ingredients: Leucine, Hypromelloses, Microcrystalline cellulose, Titanium dioxide, Gelatin,
Latest News
Related Drugs